Boeing Company (The) vs Rocket Lab Corporation — Stock Comparison
Q·Score Breakdown
6.2
Neutral
Overall
5.6
Neutral
Quality
Health
Growth
Valuation
Sentiment
BA
78% of 27 covering analysts have a positive rating.
⚠ high leverage at 8.3× debt-to-equity.
RKLB
Clean balance sheet with low leverage (0.2× debt-to-equity).
⚠ currently unprofitable (-33% margin).
Analyst Consensus
BUY
Target $269.52 (+18.5%)
25 analysts
BUY
Target $87.56 (+11.1%)
15 analysts
Fundamentals
BA
RKLB
90.2×
Trailing P/E
—
53.0×
Forward P/E
1537.8×
2.5%
Profit Margin
-32.9%
4.8%
Gross Margin
34.4%
169.9%
ROE
-18.8%
14.0%
Revenue Growth
35.7%
—
Earnings Growth
—
1.13
Beta
2.21
—
Price / Book
—
$179.2B
Market Cap
$45.6B
$177 – $254
52-Week Range
$20 – $100
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →